Fda grants breakthrough device designation to castle biosciences' decisiondx®-melanoma test

Castle announced that its decisiondx®-melanoma test has been granted breakthrough device designation from the u.s. food and drug administration (fda).

CSTL Ratings Summary

CSTL Quant Ranking